Maryam Nasimi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Maryam Nasimi has a total of 199 co-authors. Here are the top co-authors by number of shared publications:
Robabeh Abedini
Dermatology, Dermatology Department Tehran University of Medical Sciences Tehran Iran
15 shared publicationsNarges Ghandi
Dermatology, Dermatology Department Tehran University of Medical Sciences Tehran Iran
7 shared publications- Safoura Shakoei
Tehran University of Medical Sciences
7 shared publications Amir Teymourpour
Statistics, Blood transfusion Research Center High Institute for Research and Education Tehran Iran
6 shared publications- Ifa Etesami
Department of Dermatology, Razi Hospital, Tehran University of Medical Sciences, Tehran, Iran
6 shared publications Kambiz Kamyab
Department of Dermatopathology, Razi Hospital, Tehran University of Medical Sciences, Tehran, Iran
6 shared publications
Latest Publications
- Open Access
- 14 September 2026
- Published by Springer Nature in Lasers in Medical Science
- Vol. 41 (1) , 230
Comparative evaluation of long-pulsed Nd: YAG and pulsed dye lasers in the treatment of venous lake lesions: a prospective clinical study
- 14 September 2026
- Published by Springer Nature in Lasers in Medical Science
- Vol. 41 (1) , 230
Open AccessComparative evaluation of long-pulsed Nd: YAG and pulsed dye lasers in the treatment of venous lake lesions: a prospective clinical study
- Open Access
- 1 June 2026
- Published by Springer Nature in BMC Medical Education
Development and validation of the Scholarship of Teaching and Learning Assessment Questionnaire (SoTLAQ) among health professions educators
With the increasing recognition of the role of the scholarship of teaching and learning in enhancing educational quality and fostering the professional growth of health professions educators, the availability of a rigorously validated instrument to measure their awareness, attitudes, and experiences has become essential. This study aimed to design and validate a questionnaire to assess the awareness, attitudes, and experiences of faculty members involved in health professions education regarding their involvement in scholarship of teaching and learning activities. This exploratory mixed-methods research was conducted in accordance with the AMEE Guide No. 87 framework, a structured approach for instrument development and validation, to develop and validate the Scholarship of Teaching Assessment Questionnaire (SOTLAQ). Participants were recruited from faculty members at Tehran University of Medical Sciences (TUMS), Iran, using purposive sampling for the qualitative phase and convenience sampling for the quantitative phase. The initial item pool was generated from a literature review, semi-structured interviews, and a focus group discussion. The extracted codes were assessed through expert panel deliberations involving six experts in the scholarship of teaching. Eight experts assessed content validity, while face validity was evaluated through cognitive interviews with five faculty members to ensure item clarity and transparency. Construct validity was examined using exploratory factor analysis, and reliability was determined by calculating Cronbach's alpha based on responses from 165 faculty members. From the semi-structured interviews (176 codes), the literature review (37 codes), and the focus group (21 codes), a total of 30 merged codes were initially identified. Following the expert panel review, a 24-item questionnaire was finalized. The content validity index (CVI) and content validity ratio (CVR) exceeded 0.75. Exploratory factor analysis identified five factors, including "perceived awareness," "perceived skills," "perceived motivation and support," "perceived enablers and drivers," and "perceived barriers and challenges," which explained 63.3% of the variance. The overall Cronbach's alpha was 0.906. The SoTLAQ questionnaire is a valid and reliable tool for assessing key dimensions that affect faculty engagement in the scholarship of teaching activities. This questionnaire may be useful in planning educational interventions, empowerment programs, and policymaking in the field of medical education. However, further validation in diverse institutional settings and different countries is recommended before its widespread use.
- 1 June 2026
- Published by Springer Nature in BMC Medical Education
Open AccessDevelopment and validation of the Scholarship of Teaching and Learning Assessment Questionnaire (SoTLAQ) among health professions educators
With the increasing recognition of the role of the scholarship of teaching and learning in enhancing educational quality and fostering the professional growth of health professions educators, the availability of a rigorously validated instrument to measure their awareness, attitudes, and experiences has become essential. This study aimed to design and validate a questionnaire to assess the awareness, attitudes, and experiences of faculty members involved in health professions education regarding their involvement in scholarship of teaching and learning activities. This exploratory mixed-methods research was conducted in accordance with the AMEE Guide No. 87 framework, a structured approach for instrument development and validation, to develop and validate the Scholarship of Teaching Assessment Questionnaire (SOTLAQ). Participants were recruited from faculty members at Tehran University of Medical Sciences (TUMS), Iran, using purposive sampling for the qualitative phase and convenience sampling for the quantitative phase. The initial item pool was generated from a literature review, semi-structured interviews, and a focus group discussion. The extracted codes were assessed through expert panel deliberations involving six experts in the scholarship of teaching. Eight experts assessed content validity, while face validity was evaluated through cognitive interviews with five faculty members to ensure item clarity and transparency. Construct validity was examined using exploratory factor analysis, and reliability was determined by calculating Cronbach's alpha based on responses from 165 faculty members. From the semi-structured interviews (176 codes), the literature review (37 codes), and the focus group (21 codes), a total of 30 merged codes were initially identified. Following the expert panel review, a 24-item questionnaire was finalized. The content validity index (CVI) and content validity ratio (CVR) exceeded 0.75. Exploratory factor analysis identified five factors, including "perceived awareness," "perceived skills," "perceived motivation and support," "perceived enablers and drivers," and "perceived barriers and challenges," which explained 63.3% of the variance. The overall Cronbach's alpha was 0.906. The SoTLAQ questionnaire is a valid and reliable tool for assessing key dimensions that affect faculty engagement in the scholarship of teaching activities. This questionnaire may be useful in planning educational interventions, empowerment programs, and policymaking in the field of medical education. However, further validation in diverse institutional settings and different countries is recommended before its widespread use.
- Open Access
- 1 January 2026
- Published by Wiley in Dermatologic Therapy
- Vol. 2026 (1)
Smoking and Nail Psoriasis: Examining the Connection in a Case‐Control Study
Background: Nail psoriasis (NP) significantly affects patients’ quality of life and is associated with psoriasis severity. Smoking is a preventable risk factor that has been tied to poor disease outcomes, but its effect on NP is not well established. The purpose of this work is to analyze the connection between smoking and NP severity and occurrence. Methods: For this case‐control study, 218 psoriasis patients and 218 controls were enrolled. The smoking history was collected, including the time and number of cigarettes smoked per day. The Nail Psoriasis Severity Index (NAPSI) was used to assess the severity of NP. In contrast, the Psoriasis Area and Severity Index (PASI) was used to evaluate the overall severity of psoriasis. Results: The results of the study showed that the prevalence of smoking was higher among the patients with psoriasis (27.5%) as compared to controls (6.0%; p < 0.001). Among the psoriasis group, current smokers had more severe NP than nonsmokers (23.8 ± 18.6 vs. 12.3 ± 11.2, p = 0.001) as assessed by NAPSI. PASI and the incidence of psoriatic arthritis were not significantly influenced by smoking. Conclusion: In conclusion, our results suggest that smoking is significantly associated with increased severity of NP. These results highlight the importance of incorporating smoking cessation in psoriasis patients’ care. Our study adds to the body of literature that highlights the importance of lifestyle changes such as smoking cessation for the improvement of NP. Prospective studies are required to investigate the impact of smoking cessation on the development and severity of NP.
- 1 January 2026
- Published by Wiley in Dermatologic Therapy
- Vol. 2026 (1)
Open AccessSmoking and Nail Psoriasis: Examining the Connection in a Case‐Control Study
Background: Nail psoriasis (NP) significantly affects patients’ quality of life and is associated with psoriasis severity. Smoking is a preventable risk factor that has been tied to poor disease outcomes, but its effect on NP is not well established. The purpose of this work is to analyze the connection between smoking and NP severity and occurrence. Methods: For this case‐control study, 218 psoriasis patients and 218 controls were enrolled. The smoking history was collected, including the time and number of cigarettes smoked per day. The Nail Psoriasis Severity Index (NAPSI) was used to assess the severity of NP. In contrast, the Psoriasis Area and Severity Index (PASI) was used to evaluate the overall severity of psoriasis. Results: The results of the study showed that the prevalence of smoking was higher among the patients with psoriasis (27.5%) as compared to controls (6.0%; p < 0.001). Among the psoriasis group, current smokers had more severe NP than nonsmokers (23.8 ± 18.6 vs. 12.3 ± 11.2, p = 0.001) as assessed by NAPSI. PASI and the incidence of psoriatic arthritis were not significantly influenced by smoking. Conclusion: In conclusion, our results suggest that smoking is significantly associated with increased severity of NP. These results highlight the importance of incorporating smoking cessation in psoriasis patients’ care. Our study adds to the body of literature that highlights the importance of lifestyle changes such as smoking cessation for the improvement of NP. Prospective studies are required to investigate the impact of smoking cessation on the development and severity of NP.
- Open Access
- 1 September 2025
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 24 (9) , e70436
Evaluating the Efficacy and Safety of Deoxycholic Acid Injection in Reduction of Flank Fat
Background: Deoxycholic acid (DCA) injection is a noninvasive method for localized fat reduction, offering lower risks compared to invasive techniques. This study evaluates the safety and efficacy of DCA injections for reducing flank fat. Aims: We assessed the efficacy and safety of DCA injections for flank fat reduction over a 12‐week period using imaging, anthropometric data, Global Aesthetic Improvement Scale (GAIS) scoring, participant satisfaction, and standardized adverse event reporting. Patients/Methods: Adults aged 21–65 years with mild to moderate flank fat (≥ 2 cm) received two sessions of 10 mg/mL DCA injections, 6 weeks apart. Standardized ultrasound and caliper measurements were performed prior to each session. Injections were administered at 0.1–0.15 mL per 1 × 1 cm 2 area, with a maximum of 2 mL per flank per session, following standardized marking and injection protocols. Results: Thirty participants (mean age 34.9 years; 86.7% female) completed the study. By Week 12, 86.7% showed aesthetic improvement based on GAIS score, with significant reductions in waist circumference and fat thickness (measured using caliper and ultrasound; p < 0.001). The procedure was generally safe, with most adverse events being mild to moderate and limited to the injection site. Conclusion: DCA injections effectively reduced localized flank fat after two treatment sessions, resulting in significant aesthetic improvements. Adverse events were mostly mild and manageable, with no serious complications.
- 1 September 2025
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 24 (9) , e70436
Open AccessEvaluating the Efficacy and Safety of Deoxycholic Acid Injection in Reduction of Flank Fat
Background: Deoxycholic acid (DCA) injection is a noninvasive method for localized fat reduction, offering lower risks compared to invasive techniques. This study evaluates the safety and efficacy of DCA injections for reducing flank fat. Aims: We assessed the efficacy and safety of DCA injections for flank fat reduction over a 12‐week period using imaging, anthropometric data, Global Aesthetic Improvement Scale (GAIS) scoring, participant satisfaction, and standardized adverse event reporting. Patients/Methods: Adults aged 21–65 years with mild to moderate flank fat (≥ 2 cm) received two sessions of 10 mg/mL DCA injections, 6 weeks apart. Standardized ultrasound and caliper measurements were performed prior to each session. Injections were administered at 0.1–0.15 mL per 1 × 1 cm 2 area, with a maximum of 2 mL per flank per session, following standardized marking and injection protocols. Results: Thirty participants (mean age 34.9 years; 86.7% female) completed the study. By Week 12, 86.7% showed aesthetic improvement based on GAIS score, with significant reductions in waist circumference and fat thickness (measured using caliper and ultrasound; p < 0.001). The procedure was generally safe, with most adverse events being mild to moderate and limited to the injection site. Conclusion: DCA injections effectively reduced localized flank fat after two treatment sessions, resulting in significant aesthetic improvements. Adverse events were mostly mild and manageable, with no serious complications.
- 20 August 2025
- Published by Springer Nature in Archives of Dermatological Research
- Vol. 317 (1) , 1-9
Efficacy and safety of oral minoxidil in comparison to topical form in male pattern hair loss
- 20 August 2025
- Published by Springer Nature in Archives of Dermatological Research
- Vol. 317 (1) , 1-9
Efficacy and safety of oral minoxidil in comparison to topical form in male pattern hair loss
- 13 February 2025
- Published by Wiley in Journal of Cutaneous Pathology
- Vol. 52 (5) , 386-391
Clinical and Histopathological Insights Into Lupus Miliaris Disseminatus Faciei: A Review of 70 Cases
Background: Lupus miliaris disseminatus faciei (LMDF) is a granulomatous inflammatory disease often manifesting on the face as red, brown, or yellow papules. Lesions can cause scarring and disfigurement. There is no standard treatment due to a limited understanding of the etiology. Method: This review examines the clinical and histopathological characteristics of 70 LMDF patients who were diagnosed from 2016 to 2022. Results: The patients' mean age was 32.43, with a majority being in their 20s and 30s. Females were more affected during the fourth decade and beyond. The average disease duration among patients was 7.2 months. All of them had facial involvement, mostly around the eyes and on the eyelids. Histopathological analysis revealed epithelioid granulomas with inflammatory cell infiltration and, in some cases, central caseous necrosis. A relationship between the granuloma and the pilosebaceous unit was seen in 75.7% of cases. Epidermal changes, like acanthosis, were found in 47.1% of cases. We also report the existence of linear vessels in 25 (35.7%) cases. Conclusion: Most authors now consider LMDF a distinct entity, but because of its resemblance to other diseases like granulomatous rosacea, the diagnosis is challenging. Unlike many studies in this field, we provide a quite large sample and report telangiectasia in LMDF patients, which highlights the importance of precisely differentiating LMDF from rosacea. Delay in diagnosis and treatment increases the risk of scarring. Overall, we believe this study provides valuable insights into the demographics and histopathology of LMDF, contributing to the understanding of this challenging skin disorder.
- 13 February 2025
- Published by Wiley in Journal of Cutaneous Pathology
- Vol. 52 (5) , 386-391
Clinical and Histopathological Insights Into Lupus Miliaris Disseminatus Faciei: A Review of 70 Cases
Background: Lupus miliaris disseminatus faciei (LMDF) is a granulomatous inflammatory disease often manifesting on the face as red, brown, or yellow papules. Lesions can cause scarring and disfigurement. There is no standard treatment due to a limited understanding of the etiology. Method: This review examines the clinical and histopathological characteristics of 70 LMDF patients who were diagnosed from 2016 to 2022. Results: The patients' mean age was 32.43, with a majority being in their 20s and 30s. Females were more affected during the fourth decade and beyond. The average disease duration among patients was 7.2 months. All of them had facial involvement, mostly around the eyes and on the eyelids. Histopathological analysis revealed epithelioid granulomas with inflammatory cell infiltration and, in some cases, central caseous necrosis. A relationship between the granuloma and the pilosebaceous unit was seen in 75.7% of cases. Epidermal changes, like acanthosis, were found in 47.1% of cases. We also report the existence of linear vessels in 25 (35.7%) cases. Conclusion: Most authors now consider LMDF a distinct entity, but because of its resemblance to other diseases like granulomatous rosacea, the diagnosis is challenging. Unlike many studies in this field, we provide a quite large sample and report telangiectasia in LMDF patients, which highlights the importance of precisely differentiating LMDF from rosacea. Delay in diagnosis and treatment increases the risk of scarring. Overall, we believe this study provides valuable insights into the demographics and histopathology of LMDF, contributing to the understanding of this challenging skin disorder.
- Open Access
- 8 January 2025
- Published by Oxford University Press (OUP) in Aesthetic Surgery Journal Open Forum
- Vol. 7
Ultrasound-Guided Hyaluronidase Injections for the Management of Filler-Induced Arterial Ischemia: A Pictorial Case Series and Systematic Review of Literature
The use of fillers for cosmetic purposes has increased in recent years. Although generally considered safe, fillers are not exempt from complications, including ischemic events. Arterial ischemia is a rare but potentially serious complication that requires prompt recognition and management. Ultrasound-guided hyaluronidase injection is emerging as a precise and effective treatment approach. The authors present a pictorial case series of filler-induced arterial ischemia managed with ultrasound-guided hyaluronidase injections, and systematically review the literature on ultrasound findings, enzyme dosage, time to resolution, and overall effectiveness of this approach. They present 3 cases of filler-induced arterial ischemia in the frontal, nasal, and temporal regions with visible intravascular thrombosis managed with ultrasound-guided intravascular hyaluronidase injections. Additionally, the authors systematically reviewed literature from PubMed/Medline, Scopus, Embase, and Web of Science up to August 2024 to evaluate the effectiveness, dosage, and ultrasound techniques utilized in the ultrasound-guided treatment of vascular complications from hyaluronic acid fillers. Following Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines, we screened 88 studies, finally including 9 studies after full-text evaluation. Data from these studies, alongside our 3 cases (totaling 83 cases), showed rapid resolution of symptoms and ultrasound abnormalities following ultrasound-guided hyaluronidase injections. Delayed hyaluronidase administration was associated with slower or incomplete recovery, highlighting the importance of early intervention. Ultrasound-guided hyaluronidase injections effectively resolve arterial ischemia caused by filler injections, with early intervention significantly enhancing outcomes. Prompt diagnosis and timely ultrasound-guided intervention should be emphasized in clinical practice. Further large-scale randomized studies are necessary to establish standardized treatment protocols for dosage and timing. Level of Evidence: 3 (Therapeutic)
- 8 January 2025
- Published by Oxford University Press (OUP) in Aesthetic Surgery Journal Open Forum
- Vol. 7
Open AccessUltrasound-Guided Hyaluronidase Injections for the Management of Filler-Induced Arterial Ischemia: A Pictorial Case Series and Systematic Review of Literature
The use of fillers for cosmetic purposes has increased in recent years. Although generally considered safe, fillers are not exempt from complications, including ischemic events. Arterial ischemia is a rare but potentially serious complication that requires prompt recognition and management. Ultrasound-guided hyaluronidase injection is emerging as a precise and effective treatment approach. The authors present a pictorial case series of filler-induced arterial ischemia managed with ultrasound-guided hyaluronidase injections, and systematically review the literature on ultrasound findings, enzyme dosage, time to resolution, and overall effectiveness of this approach. They present 3 cases of filler-induced arterial ischemia in the frontal, nasal, and temporal regions with visible intravascular thrombosis managed with ultrasound-guided intravascular hyaluronidase injections. Additionally, the authors systematically reviewed literature from PubMed/Medline, Scopus, Embase, and Web of Science up to August 2024 to evaluate the effectiveness, dosage, and ultrasound techniques utilized in the ultrasound-guided treatment of vascular complications from hyaluronic acid fillers. Following Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines, we screened 88 studies, finally including 9 studies after full-text evaluation. Data from these studies, alongside our 3 cases (totaling 83 cases), showed rapid resolution of symptoms and ultrasound abnormalities following ultrasound-guided hyaluronidase injections. Delayed hyaluronidase administration was associated with slower or incomplete recovery, highlighting the importance of early intervention. Ultrasound-guided hyaluronidase injections effectively resolve arterial ischemia caused by filler injections, with early intervention significantly enhancing outcomes. Prompt diagnosis and timely ultrasound-guided intervention should be emphasized in clinical practice. Further large-scale randomized studies are necessary to establish standardized treatment protocols for dosage and timing. Level of Evidence: 3 (Therapeutic)
- Open Access
- 12 May 2024
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 23 (9) , 2807-2813
Safety and efficacy of tofacitinib in 97 alopecia areata patients
Background: Alopecia areata (AA) is a recurrent immune‐mediated disorder causing hair loss without any scarring being present. It affects hairs on the head or other parts of the body and can occur at any age and in both genders. It seems that AA is associated with a higher rate of psychological disorders resulting from hair loss and the esthetic and social repercussions of it. Common treatments like corticosteroids do not work for every patient and recent treatment options focusing on the immunologic mechanisms like tofacitinib have shown some promising results. Methods: It's a retrospective study on patients with AA, AT, AU taking oral tofacitinib as a treatment for at least 6 months. Scalp hair loss was assessed before treatment and at each visit using the Severity of Alopecia Tool (SALT) score. Results: Of 97 cases, 69.1% demonstrated over 50% SALT score improvement, with 44.3% having 90% or more decrease in SALT score. Patients who suffered from patchy AA were more responsive compared to patients with AT and AU subtypes and had a greater percent change in SALT score. Tofacitinib was tolerated quite well and no significant adverse events were reported. Conclusions: Tofacitinib should be taken into consideration as an efficacious treatment option for patients with AA, AT and AU.
- 12 May 2024
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 23 (9) , 2807-2813
Open AccessSafety and efficacy of tofacitinib in 97 alopecia areata patients
Background: Alopecia areata (AA) is a recurrent immune‐mediated disorder causing hair loss without any scarring being present. It affects hairs on the head or other parts of the body and can occur at any age and in both genders. It seems that AA is associated with a higher rate of psychological disorders resulting from hair loss and the esthetic and social repercussions of it. Common treatments like corticosteroids do not work for every patient and recent treatment options focusing on the immunologic mechanisms like tofacitinib have shown some promising results. Methods: It's a retrospective study on patients with AA, AT, AU taking oral tofacitinib as a treatment for at least 6 months. Scalp hair loss was assessed before treatment and at each visit using the Severity of Alopecia Tool (SALT) score. Results: Of 97 cases, 69.1% demonstrated over 50% SALT score improvement, with 44.3% having 90% or more decrease in SALT score. Patients who suffered from patchy AA were more responsive compared to patients with AT and AU subtypes and had a greater percent change in SALT score. Tofacitinib was tolerated quite well and no significant adverse events were reported. Conclusions: Tofacitinib should be taken into consideration as an efficacious treatment option for patients with AA, AT and AU.
- Open Access
- 13 April 2024
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 23 (8) , 2736-2742
Trichoscopic findings in children and adults with alopecia areata: A comparative study
Background: Alopecia areata is a chronic and relapsing condition that affects individuals of all age groups. Dermoscopy is a popular and non‐invasive method for diagnosing alopecia areata. This study aimed to analyze dermoscopic findings and their relationship with age, gender, appearance, and clinical signs in children and adults.Methods: This retrospective cross‐sectional study was conducted on 124 children and adults diagnosed with alopecia areata who were referred to a Hospital in Iran between 2021 and 2022. After reaching the calculated sample size, trichoscopic findings were examined and the results were recorded. Data analysis was performed by a statistician and presented in relevant tables.Results: The participants in the study comprised 53.2% female children, 46.8% male children, 27.42% adult males, and 72.58% adult females. The median age in the pediatric group was 10 years, while it was 27 years in the adult group. Yellow dots were significantly less observed in children than in adults (29% vs. 48.4%), while exclamation mark hairs were significantly more common in children than adults (38.7% vs. 21%). No significant differences were found in the frequency of other trichoscopic features between children and adults. Specifically, black dots, broken hairs, short vellus hairs, pigtail hairs, and empty follicular openings were observed in 38.7%, 40.3%, 32.3%, 11.3%, and 75.8% of children, respectively, and in 35.5%, 32.3%, 21%, 46.8%, and 12.9% of adults, respectively.Conclusion: The most common trichoscopic findings in alopecia areata in children are empty follicular openings and broken hairs, while exclamation mark hairs are more common in children than adults. In contrast, yellow dots are less frequently observed in children compared to adults. This distinct difference between children's and adults' dermoscopic findings highlights the critical need for age‐specific considerations in AA evaluations.
- 13 April 2024
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 23 (8) , 2736-2742
Open AccessTrichoscopic findings in children and adults with alopecia areata: A comparative study
Background: Alopecia areata is a chronic and relapsing condition that affects individuals of all age groups. Dermoscopy is a popular and non‐invasive method for diagnosing alopecia areata. This study aimed to analyze dermoscopic findings and their relationship with age, gender, appearance, and clinical signs in children and adults.Methods: This retrospective cross‐sectional study was conducted on 124 children and adults diagnosed with alopecia areata who were referred to a Hospital in Iran between 2021 and 2022. After reaching the calculated sample size, trichoscopic findings were examined and the results were recorded. Data analysis was performed by a statistician and presented in relevant tables.Results: The participants in the study comprised 53.2% female children, 46.8% male children, 27.42% adult males, and 72.58% adult females. The median age in the pediatric group was 10 years, while it was 27 years in the adult group. Yellow dots were significantly less observed in children than in adults (29% vs. 48.4%), while exclamation mark hairs were significantly more common in children than adults (38.7% vs. 21%). No significant differences were found in the frequency of other trichoscopic features between children and adults. Specifically, black dots, broken hairs, short vellus hairs, pigtail hairs, and empty follicular openings were observed in 38.7%, 40.3%, 32.3%, 11.3%, and 75.8% of children, respectively, and in 35.5%, 32.3%, 21%, 46.8%, and 12.9% of adults, respectively.Conclusion: The most common trichoscopic findings in alopecia areata in children are empty follicular openings and broken hairs, while exclamation mark hairs are more common in children than adults. In contrast, yellow dots are less frequently observed in children compared to adults. This distinct difference between children's and adults' dermoscopic findings highlights the critical need for age‐specific considerations in AA evaluations.
- Open Access
- 1 April 2024
- Published by Wiley in Health Science Reports
- Vol. 7 (4) , e2020
Clinical and demographic characteristics associated with nail involvement in alopecia areata: A cross‐sectional study of 197 patients
Background and Aims: Alopecia areata (AA) is an immune‐mediated nonscarring alopecia. Nail changes are a common disfiguring feature of AA with an average prevalence of 30%. We aimed to evaluate the frequency of different types of nail changes and determine demographic and clinical associations.Methods: This cross‐sectional study included 197 AA patients. Demographic and clinical variables including the Severity of Alopecia Tool (SALT) score, type of AA, and nail changes were evaluated.Results: Among 197 AA patients with a mean age of 28.95 ± 14.45 years, 50.3% were female. Nail changes were detected in 165 patients (83.8%). The most frequent nail abnormalities were pitting (53.3%), linear line (46.7%), and distal notching (26.9%). AA patients with nail abnormalities were significantly younger than patients without nail changes (25.31 ± 14.96 vs. 32.22 ± 9.77 years; p < 0.001). Considering age groups, younger children (less than 10 years) were more likely to have nail changes than adults (97.1% vs. 76.5%; p < 0.001). The prevalence of linear line (69.6%) and distal notching (46.4%) were significantly higher in the universalis variant compared to other variants (p < 0.001). Pitting (54.5%), distal notching (43.9%), and koilonychia (12.1%) were the most common nail changes in severe forms compared to mild‐to‐moderate forms (p < 0.009).Conclusions: Our study revealed that young patients with severe disease are prone to nail abnormalities. Pitting, distal notching, and linear line were the most common nail changes. Of note, koilonychia, leukonychia, and red spots lunula are more expected in more severe AA.
- 1 April 2024
- Published by Wiley in Health Science Reports
- Vol. 7 (4) , e2020
Open AccessClinical and demographic characteristics associated with nail involvement in alopecia areata: A cross‐sectional study of 197 patients
Background and Aims: Alopecia areata (AA) is an immune‐mediated nonscarring alopecia. Nail changes are a common disfiguring feature of AA with an average prevalence of 30%. We aimed to evaluate the frequency of different types of nail changes and determine demographic and clinical associations.Methods: This cross‐sectional study included 197 AA patients. Demographic and clinical variables including the Severity of Alopecia Tool (SALT) score, type of AA, and nail changes were evaluated.Results: Among 197 AA patients with a mean age of 28.95 ± 14.45 years, 50.3% were female. Nail changes were detected in 165 patients (83.8%). The most frequent nail abnormalities were pitting (53.3%), linear line (46.7%), and distal notching (26.9%). AA patients with nail abnormalities were significantly younger than patients without nail changes (25.31 ± 14.96 vs. 32.22 ± 9.77 years; p < 0.001). Considering age groups, younger children (less than 10 years) were more likely to have nail changes than adults (97.1% vs. 76.5%; p < 0.001). The prevalence of linear line (69.6%) and distal notching (46.4%) were significantly higher in the universalis variant compared to other variants (p < 0.001). Pitting (54.5%), distal notching (43.9%), and koilonychia (12.1%) were the most common nail changes in severe forms compared to mild‐to‐moderate forms (p < 0.009).Conclusions: Our study revealed that young patients with severe disease are prone to nail abnormalities. Pitting, distal notching, and linear line were the most common nail changes. Of note, koilonychia, leukonychia, and red spots lunula are more expected in more severe AA.